Status:
UNKNOWN
Efficacy of Misoprostol in Prevention of Neonatal Respiratory Morbidity in Parturient at Early Term Elective Caesarian Section
Lead Sponsor:
Ain Shams University
Conditions:
Transient Tachypnea of the Newborn
Neonatal Respiratory Distress
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
Neonatal respiratory morbidities represent a common group of post natal complications including respiratory distress syndrome, transient tachypnea of newborn, and persistent pulmonary hypertension of ...
Eligibility Criteria
Inclusion
- Age: 18 years or more.
- Early term singleton pregnancy.
- Elective caesarian section at (37 - 38+6) weeks of gestation.
- Any indication for lower uterine segment caesarian section other than labor (as malpresentations, severe preeclampsia, placenta previa with no previous bleeding attacks, Diabetes Mellitus, macrosomic fetus, non reassuring cardiotocogram (CTG), and fetal growth restriction).
- Informed written consent signed by the participating pregnant woman.
Exclusion
- Women having any contraindication to Prostaglandin E1 as hypersensitivity, respiratory disease (especially bronchial asthma), or glaucoma.
- Any mental problems that block understanding of the nature and all the possible consequences of the procedure and the study.
- Pregnancies of known fetal diseases or chromosomal abnormalities.
- Non-singleton pregnancies.
- Emergency caesarian section as in ruptured membrane and women in labor pain.
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2021
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT04780412
Start Date
September 1 2020
End Date
March 1 2021
Last Update
March 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University - Faculty of Medicine
Cairo, Egypt